Multiple studies have demonstrated that recombinant human BMP4 (rhBMP4) holds potent therapeutic impact for GBM and was investigated in clinical trials for recurrent disease (NCT02869243).28, 31, 32. This evidence concerns the gene BMP4 and glioblastoma.